WHO seeks more data from Sputnik V makers for granting Emergency Use Listing


PTI, Sep 11, 2021, 12:13 PM IST

 

The World Health Organization has sought some more data from Russia’s Gamaleya National Research Institute of Epidemiology and Microbiology, developer of Covid-19 vaccine Sputnik V for according Emergency Use Listing status for the jab.

Sputnik V is currently manufactured in India and being sold by Dr Reddy’s Laboratories under Emergency Use Authorisation route. According to WHO website, though several meetings were held as part of the process for EUL, the status of assessment column says “On hold, awaiting completion of rolling submission”.

“Anticipated date will be set once all data is submitted and follow-up of inspection observations completed,” WHO said on the decision date for EUL.

Back home, Panacea Biotec supplied the first shipment of the second component of the Russian Sputnik V vaccine manufactured by it for sale in India on September 7.

This is the first batch of the second component produced and supplied by the company in India, the drug firm and the Russian Direct Investment Fund (RDIF) had said in a joint statement. RDIF has tied up with six Indian drug makers to manufacture Sputnik V and their supplies are expected to roll out by August or September, as senior official of Dr Reddy’s had said earlier.

The global health body is currently reviewing Bharat Biotech’s application for an Emergency Use Listing of its Covid-19 vaccine Covaxin.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

10 month baby gets new heart, new life

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial

100 engineering colleges in Karnataka to be ‘adopted’ by corporates by next year: IT Minister Kharge

Siddaramaiah defends BPL ration card cancellation, says only ineligible beneficiaries affected

China announces new policy measures to protect its exports from Trump’s new tariff threat

Renovated Medical Oncology OPD and Chemotherapy Day Care Centre inaugurated at Kasturba Hospital, Manipal

Related Articles More

India-US ties have strong foundation: White House confident in navigating crisis over Adani bribery charges

PM Modi leaves for home after concluding three-nation visit

China announces new policy measures to protect its exports from Trump’s new tariff threat

Pak government prepares for proposed protest by former PM Imran Khan’s party on Nov 24

Gangster Lawrence Bishnoi’s brother Anmol arrested in US, lodged in Iowa jail

MUST WATCH

Christmas Cake Fruit Mixing

DK Shivakumar

Rose Cultivation

Geethotsava

Naxal Operation


Latest Additions

Fraudsters create fake FB profile misusing Udupi DC’s identity, case filed

Investigation begins into Naxal Encounter; Where did the others escape?

Mumbai terror accused Rana approaches US Supreme Court to challenge extradition to India

Who will be next Maharashtra CM? Mahayuti, MVA constituents drop different names

Geethartha Chinthane 101: Understanding of universality eases grief

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.